Ovulation induction with gonadotropin in patients with thalassemia pretreated with pulsatile GnRH: Outcome [1];Induzione dell'ovulazione con gonadotropine in pazienti talassemiche pretrattate con GnRH pulsatile: Outcome

Minerva Ginecologica

Volumn 56, Issue 5, 2004, Pages 485-487

  Vizziello, G ^a,b   Carone, D ^b   Caroppo, E ^b   Vitti, A ^b   Pasquadibisceglie, A ^b   D'Amato, G ^b  

^a IRCCS S de Bellis Castellana Grotte ^*  (Italy)

^b NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; ESTRADIOL; FOLLITROPIN; GONADORELIN; GONADORELIN ACETATE; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN;

ADULT; CASE REPORT; COMORBIDITY; DRUG EFFICACY; FEMALE; FEMALE INFERTILITY; FETUS OUTCOME; HUMAN; LETTER; OVULATION INDUCTION; PREGNANCY RATE; THALASSEMIA MAJOR;

ADULT; BETA-THALASSEMIA; CHORIONIC GONADOTROPIN; DRUG COMBINATIONS; FEMALE; FERTILITY AGENTS, FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; HYPOGONADISM; MENOTROPINS; OVULATION INDUCTION; TREATMENT OUTCOME;

EID: 11144299594     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Italian Working Group on Endocrine Complications in Non-endocrine Diseases. Multicentre study on prevalence of endocrine complications in thalassaemia major. Clin Endocrinol 1995;42:581-6.
2. Tiosano D, Hochberg Z. Endocrine complications of thalassemia. J Endocrinol Invest 2001;24:716-23.
3. Psihogios V, Rodda C, Reid E, Clark M, Clarke C, Bowden D. Reproductive health in individuals with homozygous beta-thalassemia: knowledge, attitudes, and behavior. Fertil Steril 2002;77:119-27.
4. Cao A, Galanello R, Rosatelli MC, Argiolu F, De Virgiliis S. Clinical experience of management of thalassaemia: the Sardinia experience Semin Haematol 1996;33:66-75.
5. Skordis N, Christou S, Koliou M, Pavlides N, Angastiniotis M. Fertility in female patients with thalassemia. J Pediatr Endocrinol Metab 1998;11(Suppl 3):935-43.